Human care company Elekta AB (STO:EKTAB.ST) announced on Tuesday that 21st Century Oncology, a large radiation oncology provider in the US, will replace several of its existing linear accelerators, as well as treatment planning software and oncology information systems, with advanced cancer treatment solutions from Elekta.

Under this deal, USD22m has been booked by the company in the second quarter of fiscal year 2017/18. First deliveries of the new order are scheduled to begin in April 2018 to centres in the US.

This agreement, include Elekta's Versa HD linear accelerators, which combines high definition dynamic radiosurgery and precision radiation therapy treatments throughout the body in a single platform.

It also includes Elekta's MOSAIQ oncology information system that enables optimisation in health care practices through intelligent automation and actionable analytics.

In addition, 21st Century Oncology will also upgrade to Monaco a state-of-the-art treatment planning solution that powers efficient high definition treatment planning with gold -standard accuracy.

Elekta provides treatment solutions and oncology informatics portfolios that are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy.